245 related articles for article (PubMed ID: 34085164)
1. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report.
Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oki E; Nakamura Y; Yoshino T; Mori M
Clin J Gastroenterol; 2021 Oct; 14(5):1459-1463. PubMed ID: 34085164
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic Cholangiocarcinoma with High Microsatellite Instability and Tumor Mutation Burden That Responded Significantly to Pembrolizumab but Perforated within a Short Period.
Yamazaki S; Kubota K; Shimizu A; Notake T; Umemura K; Kamachi A; Goto T; Tomida H; Yamashita N; Sato M; Kanno H; Soejima Y
Intern Med; 2024 Apr; 63(8):1105-1112. PubMed ID: 37779076
[TBL] [Abstract][Full Text] [Related]
3. [A case of unresectable intrahepatic cholangiocarcinoma receiving sustainable pembrolizumab therapy].
Matsushita S; Ueo T; Minami R; Ozawa T; Matsumoto A; Kimura Y; Takeda Y; Okano A; Kusumi F; Ohana M
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(4):360-367. PubMed ID: 35400689
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite Instability-high Intrahepatic Cholangiocarcinoma with Portal Vein Tumor Thrombosis Successfully Treated with Pembrolizumab.
Naganuma A; Sakuda T; Murakami T; Aihara K; Watanuki Y; Suzuki Y; Shibasaki E; Masuda T; Uehara S; Yasuoka H; Hoshino T; Kudo T; Ishihara H; Ogawa T; Kitamoto Y; Ogawa A
Intern Med; 2020 Sep; 59(18):2261-2267. PubMed ID: 32536644
[TBL] [Abstract][Full Text] [Related]
5. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
[TBL] [Abstract][Full Text] [Related]
6. A metastatic intrahepatic cholangiocarcinoma treated with programmed cell death 1 inhibitor: a case report and literature review.
Zhang J; Wu L; Liu J; Lin M
Immunotherapy; 2020 Jun; 12(8):555-561. PubMed ID: 32372672
[TBL] [Abstract][Full Text] [Related]
7. PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma: a case report and literature review.
Liao CX; Deng CS; Liang X; Yang JC; Chen ZZ; Lin XY; Lin CF; Chen S; Wu SS
Front Immunol; 2023; 14():1239168. PubMed ID: 37753076
[TBL] [Abstract][Full Text] [Related]
8. Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case report.
Eguchi S; Shinkawa H; Sato Y; Nakai K; Takemura S; Tanaka S; Amano R; Kimura K; Ohira G; Nishio K; Kinoshita M; Tauchi J; Miyazaki T; Ishihara A; Shirai D; Kubo S
Clin J Gastroenterol; 2021 Jun; 14(3):858-865. PubMed ID: 33811313
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
[TBL] [Abstract][Full Text] [Related]
10. Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.
Liu X; Yao J; Song L; Zhang S; Huang T; Li Y
J Immunother Cancer; 2019 Aug; 7(1):204. PubMed ID: 31383016
[TBL] [Abstract][Full Text] [Related]
11. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
[TBL] [Abstract][Full Text] [Related]
12. Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
Nakamura M; Ueno M; Hayami S; Kawai M; Miyamoto A; Suzaki N; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Kojima F; Yamaue H
Anticancer Res; 2020 Jul; 40(7):4123-4129. PubMed ID: 32620661
[TBL] [Abstract][Full Text] [Related]
13. First Reported Case of Primary Intrahepatic Cholangiocarcinoma with Pure Squamous Cell Histology: A Case Report.
Lubana SS; Singh N; Seligman B; Tuli SS; Heimann DM
Am J Case Rep; 2015 Jul; 16():438-44. PubMed ID: 26158884
[TBL] [Abstract][Full Text] [Related]
14. A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Arihiro K; Takahashi S
Clin J Gastroenterol; 2022 Dec; 15(6):1164-1168. PubMed ID: 36181621
[TBL] [Abstract][Full Text] [Related]
15. Significant response to transarterial chemoembolization combined with PD-1 inhibitor and apatinib for advanced intrahepatic cholangiocarcinoma: A case report and literature review.
Zhang H; Han C; Zheng X; Zhao W; Liu Y; Ye X
J Cancer Res Ther; 2023 Aug; 19(4):1055-1060. PubMed ID: 37675736
[TBL] [Abstract][Full Text] [Related]
16. Clinical response to adding pyrotinib to pembrolizumab and lenvatinib for HER2-positive advanced intrahepatic cholangiocarcinoma: a case report.
Zhang JW; Yang X; Pan B; Xu Y; Lu X; Zhao HT
World J Surg Oncol; 2023 Mar; 21(1):108. PubMed ID: 36973682
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report.
Inoue M; Hakoda K; Sawada H; Hotta R; Ohmori I; Miyamoto K; Toyota K; Sadamoto S; Takahashi T
J Med Case Rep; 2022 Jan; 16(1):30. PubMed ID: 35039070
[TBL] [Abstract][Full Text] [Related]
18. Duct of Luschka diagnosed by sonography in a patient with bile duct carcinoma and intrahepatic bile duct dilatation.
Watanabe M; Shiozawa K; Kishimoto Y; Mimura T; Ito K; Kamata I; Kanayama M; Kikuchi Y; Igarashi Y; Sumino Y
J Clin Ultrasound; 2013; 41(9):558-62. PubMed ID: 23055263
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Cholangiocellular Carcinoma in Lynch Syndrome Treated by an Immune Checkpoint Inhibitor].
Shinke G; Takeda Y; Ohmura Y; Katsura Y; Haruna K; Kihara Y; Kusafuka H; Sakaue M; Katsuyama S; Kawai K; Hiraki M; Masuzawa T; Takeno A; Hata T; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2014-2016. PubMed ID: 35045478
[TBL] [Abstract][Full Text] [Related]
20. Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer.
Kai Y; Ikezawa K; Takada R; Daiku K; Maeda S; Abe Y; Yamai T; Fukutake N; Nakabori T; Uehara H; Nagata S; Wada H; Ohkawa K
JGH Open; 2021 Jun; 5(6):712-716. PubMed ID: 34124390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]